Navigation Links
Update on velaglucerase alfa
Date:9/8/2009

physician.

In addition, Shire is working with regulatory authorities towards the approval of velaglucerase alfa and has announced, earlier last week, that based on the positive results from all phase 3 trials, it has submitted the New Drug Application to the U.S. Food & Drug Administration and is expected to submit the EU application by year end.

In order to help physicians plan with their patients, Shire has today sent a letter to physicians in the U.S. This letter is to be posted on http://www.gaucherpatients.com.

Notes to editors

SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights. Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's website: http://www.shire.com.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materi
'/>"/>

SOURCE Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Cardio3 BioSciences Presents Update on C-Cure(R) Second Generation Stem Cell Therapy for Heart Failure at European Society of Cardiology Congress
2. ThromboGenics NV Announces Business Update and Half Year Results 2009
3. Wyeth Provides Regulatory Update on Prevnar 13* in the United States
4. ThermoGenesis Provides Update on Fiscal 2009 Results
5. ADVENTRX to Hold Second Quarter Results and Business Update Conference Call on August 12
6. GeoVax Labs, Inc. Provides Clinical Studies Update
7. Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update
8. SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS
9. Revised: Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
10. Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
11. Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... BOSTON , Aug. 28, 2014  Next month, executives ... at three key industry events beginning with Patient-Centered Clinical ... Hotel in Boston , September 4-5. Patient ... , and Aaron Fleishman will share insights on ... how a variety of tactics – from media to mobile ...
(Date:8/28/2014)... USA (PRWEB) August 27, 2014 Scientists, ... month for SPIE Laser Damage 2014 symposium. ... materials for high-power lasers will run 14-17 September. The ... for optics and photonics . , The premier conference ... understanding laser damage to optical materials will engage researchers ...
(Date:8/28/2014)... Whitehouse Laboratories is excited to announce ... PTI Inspection Systems that will enable it ... art leak testing method development and validation programs using ... As part of this agreement, Whitehouse Labs has taken ... Instrument developed and manufactured by PTI. The HVLD ...
(Date:8/27/2014)... Aug. 27, 2014 Reportlinker.com announces ... available in its catalogue: Global ... http://www.reportlinker.com/p02316661/Global-Biodegradable-Packaging-Materials-Market-2014-2018.html About ... that are readily decomposed by the action ... non-degradable packaging in terms of raw materials, ...
Breaking Biology Technology:BBK Worldwide Leads Sessions at Key September Events 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 3Whitehouse Labs Renews Partnership with PTI Inspection Systems 2Whitehouse Labs Renews Partnership with PTI Inspection Systems 3Global Biodegradable Packaging Materials Market 2014-2018 2Global Biodegradable Packaging Materials Market 2014-2018 3Global Biodegradable Packaging Materials Market 2014-2018 4Global Biodegradable Packaging Materials Market 2014-2018 5Global Biodegradable Packaging Materials Market 2014-2018 6Global Biodegradable Packaging Materials Market 2014-2018 7
... Dec. 14, 2010 The Association for Career and ... "CTE,s Role in Worker Retraining" that describes how ... in retraining adults and providing them the skills needed to ... retraining programs not only focus on local employment needs, but ...
... Talecris Biotherapeutics Holdings Inc. (Nasdaq: TLCR ) announced ... Superior Court Division, Wake County, North Carolina, rendered a verdict ... in favor of Plasma Centers of America, LLC, against its ... claim. Talecris had a three-year Plasma Sale/Purchase Agreement ...
... functioning light bulb and know right away that it,s hot. ... the same feedback. Rice University researchers say they ... the temperature of a molecule or flowing electrons by using ... paper from the lab of Douglas Natelson, a Rice professor ...
Cached Biology Technology:ACTE Releases Issue Brief Outlining Critical Role CTE Plays in Worker Retraining 2Talecris Biotherapeutics Announces Jury Verdict in Contract Dispute 2Rice researchers take molecule's temperature 2Rice researchers take molecule's temperature 3
(Date:8/28/2014)... news release is available in German . ... water fish, owes its name to a striking pattern of ... types, black cells, reflective silvery cells, and yellow cells emerge ... and arrange as a multilayered mosaic to compose the characteristic ... three cell types have to interact to form proper stripes, ...
(Date:8/28/2014)... (August 28, 2014) Researchers at the University of ... muscular dystrophy (FSHD) to be used for muscle regeneration ... potential therapies for FSHD. , The research is published ... Reports . , There is no treatment for FSHD, ... common type of muscular dystrophy. FSHD is an unusual ...
(Date:8/28/2014)... , Aug. 28, 2014  Privacy Advocate and Senior ... Jennifer Lynch , joins the lineup of biometric and ... annual Biometrics UnPlugged Executive Summit in Tampa, ... Previously announced speakers include Steven Rahman, Director, Technology and ... Sector at Experian. The theme of this year,s event ...
Breaking Biology News(10 mins):How the zebrafish gets its stripes 2How the zebrafish gets its stripes 3UMN researchers find animal model for understudied type of muscular dystrophy 2Biometrics UnPlugged Welcomes the Electronic Frontier Foundation's Jennifer Lynch to the Mobility at the Crossroads of Commerce and Privacy Summit 2
... leader? Traits that we look for typically include a sense ... a recent study suggests that it is not just an ... chosen as leader of a group. Previous research has implicated ... for a male versus female leader may depend on the ...
... years of near-zero growth in atmospheric methane concentrations, levels ... good news for future global warming," says CSIRO,s Dr ... in Geophysical Research Letters, a journal of the American ... important greenhouse gases, namely methane and the CFCs, had ...
... Researchers at Georgetown University Medical Center have discovered a ... to tamoxifen, the world,s largest-selling breast cancer prevention and ... way to identify tamoxifen users who are no longer ... therapy option sooner. , In the November 1 issue ...
Cached Biology News:Gender biases in leadership selection during competitions within and between groups 2Gender biases in leadership selection during competitions within and between groups 3Global methane levels on the rise again 2'New' estrogen receptor found to be key player in tamoxifen resistance 2'New' estrogen receptor found to be key player in tamoxifen resistance 3
...
Anti-Tissue Trans-glutaminase (IgA) EIA Sample Size: 10 l...
... Lysozyme Assay Kit (E-22013) provides,researchers with ... of lysozyme,activity in solution. This fluorescence-based ... 20 U/mL (Figure 1). The assay,measures ... which are labeled to such a ...
... m7G(5')ppp(5')G (Cap Analog) is used for the ... in vitro transcription reactions. Substitution of cap ... GTP in an in vitro transcription reaction ... structure into a large fraction of the ...
Biology Products: